Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping. Scientific Reports , 2025; 15 (1) DOI: 10.1038/s41598-024-81060-3 ...

At about age 4 weeks, he started to develop erythroderma and scaling. He had a history of recurrent infections, diarrhea, and failure to thrive in the first year of life. By age 2 years ...

After undergoing months of treatment with traditional therapies for erythroderma, which included the steroid prednisone, anti-itch creams, and immunosuppressive drugs, the patient experienced ...